StockNews.AI
COR
StockNews.AI
13 days

Cencora Reports Fiscal 2025 Third Quarter Results

1. Cencora, Inc. reported an 8.7% revenue increase to $80.7 billion. 2. Diluted EPS rose to $3.52, up from $2.42 YoY.

-4.89%Current Return
VS
+0.39%S&P 500
$292.3508/06 06:39 AM EDTEvent Start

$278.0408/07 01:40 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Very Bullish?

The significant revenue growth and EPS increase indicate strong company performance, potentially driving investor confidence. Historical precedents suggest that consistent revenue and earnings growth often leads to stock price appreciation in the healthcare sector.

How important is it?

Strong quarterly earnings can significantly affect COR’s stock price and investor sentiment. Such performance metrics often attract attention from analysts and potential investors.

Why Short Term?

Immediate market reactions are likely to favor COR due to strong quarterly results. Similar past earnings reports have caused swift price adjustments when exceeding analysts' expectations.

Related Companies

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year to $80.7 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.52 for the third quarter of fiscal 2025 compared to $2.42 in the prior year third quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, inc.

Related News